CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company
SELLAS Life Sciences Group, Inc.
Sign in to watch- Ticker
- SLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 6462005278
- Business address
- 7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
- Former names
- GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-06-08 | GRAY MARY ANN Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2017-06-08 | Nisi Rudolph Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2017-04-10 | Nisi Rudolph Director | Grant or award | +10,927 | $0.59 | $6K | 15,364 |
| 2017-04-10 | GRAY MARY ANN Director | Grant or award | +8,815 | $0.59 | $5K | 13,829 |
| 2017-04-10 | Hillsberg Sanford Director | Grant or award | +13,394 | $0.59 | $8K | 22,563 |
| 2017-04-10 | GALLIKER STEPHEN S Director | Grant or award | +9,865 | $0.59 | $6K | 13,416 |
| 2017-04-10 | Einhorn Irving M. Director | Grant or award | +8,638 | $0.59 | $5K | 10,953 |
| 2017-04-10 | Chin Richard Director | Grant or award | +8,107 | $0.59 | $5K | 10,527 |
| 2017-04-10 | Ashton William Director | Grant or award | +9,870 | $0.59 | $6K | 12,816 |
| 2017-02-08 | Hudson Bay Capital Management LP 10% owner | Sale | −2,363,441 | $0.84 | $2.0M | 2,036,559 |
| 2017-02-08 | Hudson Bay Capital Management LP 10% owner | Purchase · Call Options (obligation to sell) | +1,100 | $33,000.00 | $36.3M | |
| 2017-02-06 | Knapp Thomas J General Counsel | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2017-01-20 | Einhorn Irving M. Director | Grant or award | +2,525 | $1.98 | $5K | 2,525 |
| 2017-01-20 | GRAY MARY ANN Director | Grant or award | +2,525 | $1.98 | $5K | 5,004 |
| 2017-01-20 | Ashton William Director | Grant or award | +2,946 | $1.98 | $6K | 2,946 |
| 2017-01-20 | Hillsberg Sanford Director | Grant or award | +3,998 | $1.98 | $8K | 9,169 |
| 2017-01-20 | Nisi Rudolph Director | Grant or award | +3,262 | $1.98 | $6K | 4,437 |
| 2017-01-20 | Chin Richard Director | Grant or award | +2,420 | $1.98 | $5K | 2,420 |
| 2017-01-20 | GALLIKER STEPHEN S Director | Grant or award | +3,051 | $1.98 | $6K | 3,551 |
| 2017-01-17 | Nejadnik Bijan Chief Medical Officer | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 |
Page 10 of 17 · 324 trades